Basecare Medical Announces 2021 Interim Results | The preliminary results of commercialization have been achieved, the sales of PGT-A kits climbs 168%
[Hong Kong, 30 August 2021] Suzhou Basecare Medical Corporation Limited (“Basecare Medical” or the “Company”, together with its subsidiaries, the “Group”, stock code: 2170), an innovative platform of genetic testing kit solutions for assisted reproduction in China, announced its interim results for the six months ended 30 June 2021 (the “Period”).